Virginia Commonwealth University/VCU Massey Cancer Center

Richmond, Virginia 23298-0070

1 studies enrolling now · 5 studies all time

What they study most

Advanced Melanoma, Diffuse Large B-cell Lymphoma, Fallopian Tube Cancer, KEAP1 Gene Mutation, Leukemia, NFE2L2 Gene Mutation, NRF2 Gene Mutation, Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung, Non-squamous Non-small-cell Lung Cancer, Ovarian Cancer, Peritoneal Neoplasms

Studies at this site

• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
• KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early
• Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer — Completed